We are live on ! Find out more
KCM

Knoll Capital Management Portfolio holdings

AUM $180M
1-Year Est. Return 66.11%
This Fund
S&P 500
This Quarter Est. Return
+21.06%
1 Year Est. Return
+66.11%
3 Year Est. Return
+268.55%
5 Year Est. Return
+741%
10 Year Est. Return
+10,877.35%
AUM
$147M
AUM Growth
+$24.7M
Cap. Flow
+$4.23M
Cap. Flow %
2.88%
Top 10 Hldgs %
88.55%
Holding
31
New
1
Increased
3
Reduced
–
Closed
–

Top Buys

Rank Stock Value
1
APLT
Applied Therapeutics
APLT
+$2.43M
2
EIGR
Eiger BioPharmaceuticals, Inc.
EIGR
+$947K
3
ALT icon
Altimmune
ALT
+$589K
4
AVXL icon
Anavex Life Sciences
AVXL
+$263K

Top Sells

No sells this quarter

Sector Composition

Rank Sector Weight
1 Healthcare 86.45%
2 Materials 6.28%
3 Financials 1.77%
4 Communication Services 1.46%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
BHVN
1
DELISTED
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
$73.5M 50.11%
857,494
– –
APLT
2
DELISTED
Applied Therapeutics
APLT
$18.8M 12.78%
851,551
+116,571
+16% +$2.43M
EIGR
3
DELISTED
Eiger BioPharmaceuticals, Inc.
EIGR
$8.53M 5.82%
23,141
+3,300
+17% +$947K
CRBP icon
4
Corbus Pharmaceuticals
CRBP
$170M
$6.31M 4.3%
168,196
– –
ABEO icon
5
Abeona Therapeutics
ABEO
$351M
$4.49M 3.06%
114,391
– –
ALDX icon
6
Aldeyra Therapeutics
ALDX
$95.3M
$3.91M 2.66%
569,405
– –
AVXL icon
7
Anavex Life Sciences
AVXL
$234M
$3.62M 2.47%
670,789
+50,000
+8% +$263K
BX icon
8
Blackstone
BX
$105B
$2.59M 1.77%
40,000
– –
XCUR icon
9
Exicure
XCUR
$11.2M
$2.26M 1.54%
8,519
– –
LUMN icon
10
Lumen
LUMN
$6.39B
$2.15M 1.46%
220,000
– –
ENTX icon
11
Entera Bio
ENTX
$188M
$1.88M 1.28%
1,741,363
– –
DOW icon
12
Dow Inc
DOW
$20.7B
$1.67M 1.14%
30,000
– –
CTVA icon
13
Corteva
CTVA
$58.7B
$1.16M 0.79%
30,000
– –
MTEM
14
DELISTED
Molecular Templates, Inc.
MTEM
$1.07M 0.73%
7,594
– –
DD icon
15
DuPont de Nemours
DD
$18.8B
$1.07M 0.73%
11,950
– –
SNGX icon
16
Soligenix
SNGX
$5.42M
$1.01M 0.69%
3,286
– –
BTAI icon
17
BioXcel Therapeutics
BTAI
$26.9M
$924K 0.63%
1,250
– –
SA
18
Seabridge Gold
SA
$2.82B
$674K 0.46%
32,000
– –
MMX
19
DELISTED
Maverix Metals Inc. Common Shares
MMX
$628K 0.43%
115,000
– –
ALT icon
20
Altimmune
ALT
$576M
$564K 0.38%
+50,000
New +$589K
OR icon
21
OR Royalties Inc
OR
$5.55B
$551K 0.38%
190,000
– –
AEM icon
22
Agnico Eagle Mines
AEM
$73.3B
$487K 0.33%
6,900
– –
EQX icon
23
Equinox Gold
EQX
$7.52B
$470K 0.32%
45,500
– –
FNV icon
24
Franco-Nevada
FNV
$41.4B
$470K 0.32%
3,750
– –
KL
25
DELISTED
Kirkland Lake Gold Ltd Ordinary
KL
$444K 0.3%
10,750
– –
1
2

Similar funds

MGWA
Monument Group Wealth Advisors Concord, Massachusetts $180M AUM 19.81% 1-Year Est. Return
AW
Alchemi Wealth Essex, Connecticut $180M AUM
FBC
Fairfield, Bush & Co Darien, Connecticut $180M AUM 39.51% 1-Year Est. Return
AIC
Aurora Investment Counsel Atlanta, Georgia $180M AUM 0.3% 1-Year Est. Return
AG
Amiral Gestion Paris, France $180M AUM 9.43% 1-Year Est. Return
PCA
Prospect Capital Advisors Sausalito, California $180M AUM 60.99% 1-Year Est. Return
HIC
Hamrick Investment Counsel Seattle, Washington $180M AUM
FFA
Frazier Financial Advisors Columbus, Ohio $181M AUM 11.16% 1-Year Est. Return

Knoll Capital Management's Q4 2020 Portfolio in Review

As of Q4 2020, Knoll Capital Management held 31 positions worth $147M, up 20% from $122M the previous quarter. Its ten largest holdings account for 89% of the portfolio.

Trading was light in Q4 2020: portfolio turnover was 3.2%. Knoll Capital Management opened 1 new position and made no exits, leaving the 31-position portfolio largely intact.

By sector, the portfolio is most concentrated in Healthcare at 86% of assets, up from 84% a quarter earlier, followed by Materials and Financials.

  • Knoll Capital Management's largest Q4 2020 buy was Altimmune: 50,000 shares worth $564K.
  • Knoll Capital Management added most to Applied Therapeutics in Q4 2020, an estimated $2.43M increase.
  • Knoll Capital Management's ten largest holdings make up 89% of its $147M portfolio in Q4 2020.
  • Knoll Capital Management opened 1 new position and closed 0 in Q4 2020.
  • Knoll Capital Management's portfolio value rose 20% quarter-over-quarter to $147M.

Based on Knoll Capital Management's 13F filing for Q4 2020, filed 16 Feb 2021.